Monoclonal antibody (HML-1) reactivity of T-cell lymphomas

Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes.

Oncoimmunology·2021

Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A.

Biochimica et biophysica acta. Molecular basis of disease·2018

ANTI-IL-2 Receptor Antibody Treatment for Lymphoproliferative Disease: Transient Response in A Case of Ki-1+ Anaplastic Large Cell Lymphoma.

Leukemia & lymphoma·2016

IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis.

Mucosal immunology·2015

Subversion of human intestinal mucosa innate immunity by a Crohn's disease-associated E. coli.

Mucosal immunology·2014

Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study.

European journal of cancer (Oxford, England : 1990)·2013

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Lancet (London, England)·2026

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Lancet (London, England)·2026

Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial.

Lancet (London, England)·2026

Wealth redistribution policies to mitigate the impact of development assistance defunding: a retrospective evaluation and forecasting analysis up to 2030.

Lancet (London, England)·2026

IL-23 promotes PD-L1 expression and tumor immune evasion via METTL16 pathway.

American journal of cancer research·2026

Mechanism and intervention strategy of thymus atrophy in cancer immunotherapy.

American journal of cancer research·2026

Suspected recurrent sarcoma resembling feline injection-site sarcoma with spinal cord invasion in a cat.

JFMS open reports·2026

Disulfidptosis as an immunometabolic rheostat in gastrointestinal cancers: tuning the balance between T Cell exhaustion and immunogenic cell death.

Frontiers in cell and developmental biology·2026

Immune checkpoint inhibitors in thymic epithelial tumors: current evidence, immune-related toxicity, and perioperative considerations-a narrative review.

Journal of thoracic disease·2026

Molecularly guided management of pediatric endobronchial inflammatory myofibroblastic tumor: a report of two cases on surgical and targeted intervention.

Translational pediatrics·2026

Related Experiment Videos

Monoclonal antibody (HML-1) reactivity of T-cell lymphomas

Related Concept Videos

Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes.

Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A.

ANTI-IL-2 Receptor Antibody Treatment for Lymphoproliferative Disease: Transient Response in A Case of Ki-1+ Anaplastic Large Cell Lymphoma.

IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis.

Subversion of human intestinal mucosa innate immunity by a Crohn's disease-associated E. coli.

Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study.

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial.

Wealth redistribution policies to mitigate the impact of development assistance defunding: a retrospective evaluation and forecasting analysis up to 2030.

IL-23 promotes PD-L1 expression and tumor immune evasion via METTL16 pathway.

Mechanism and intervention strategy of thymus atrophy in cancer immunotherapy.

Suspected recurrent sarcoma resembling feline injection-site sarcoma with spinal cord invasion in a cat.

Disulfidptosis as an immunometabolic rheostat in gastrointestinal cancers: tuning the balance between T Cell exhaustion and immunogenic cell death.

Immune checkpoint inhibitors in thymic epithelial tumors: current evidence, immune-related toxicity, and perioperative considerations-a narrative review.

Molecularly guided management of pediatric endobronchial inflammatory myofibroblastic tumor: a report of two cases on surgical and targeted intervention.

Related Experiment Videos

Monoclonal antibody (HML-1) reactivity of T-cell lymphomas

Related Concept Videos

Related Articles